Anticoagulation therapy for the prevention of hemodialysis tunneled cuffed catheter (TCC) thrombosis

Journal of Vascular Access

Volumn 7, Issue 3, 2006, Pages 118-122

  Colì, Luigi ^a   Donati, G ^a   Cianciolo, G ^a   Raimondi, C ^a   Comai, G ^a   Panicali, L ^a   Nastasi, V ^a   Cannarile, D C ^a   Gozzetti, F ^a   Piccari, M ^a   Stefoni, S ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Hemodialysis; Prevention; Thrombosis; Tunneled cuffed catheters; Warfarin therapy

Indexed keywords

TICLOPIDINE; UROKINASE; WARFARIN;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTERY BLOOD FLOW; ARTICLE; BLEEDING; BLOOD FLOW VELOCITY; BLOOD PRESSURE MEASUREMENT; CATHETER THROMBOSIS; CONTROLLED STUDY; DIALYSIS CATHETER; DRUG EFFICACY; EARLY INTERVENTION; EXTRACORPOREAL CIRCULATION; FEMALE; FOLLOW UP; HEMODIALYSIS PATIENT; HUMAN; INTERNATIONAL NORMALIZED RATIO; MAJOR CLINICAL STUDY; MALE; RANDOMIZATION; STATISTICAL ANALYSIS; THROMBOSIS PREVENTION; VEIN BLOOD FLOW;

EID: 33750359867     PISSN: 11297298     EISSN: None     Source Type: Journal    
DOI: 10.1177/112972980600700305     Document Type: Article

References (16)

1. Feldman HI, Kobrin S, Wasserstein A. Hemodialysis vascular access morbidity. J Am Soc Nephrol 1996; 7: 523-35.
2. Riordan S, Frawley L, Gray L, Nieshe J. Primary access surgery for long-term hemodialysis. Aust N Z J Surg 1994; 64: 763-7.
3. Baracetti S. Indications for the use of central venous catheters as vascular access for hemodialysis. J Vasc Access 2001; 2: 20-7.
4. NKF-DOQI Clinical practice guidelines for vascular access: update 2000: Am J Kidney Dis 2001; 37 (suppl 1): S137-81.
5. Pisoni RL, Young EW, Dykstra DM, et al. Vascular access use in Europe and the United States: results from the DOPPS. Kidney Int 2002; 61: 305-16.
6. Twardoski ZJ. High-dose intradialytic urokinase to restore the patency of permanent central vein hemodialysis catheters. Am J Kidney Dis 1998; 31: 841-7.
7. Shwab SJ, Buller GL, McCann RL, Bollinger RR, Stickel DL. Prospective evaluation of a Dacron cuffed hemodialysis catheter for prolonged use. Am J Kidney Dis 1988; 16: 166-9.
8. Suhocki PV, Conlon PJ, Knelson MH, Harland R, Schwab SJ. Silastic cuffed catheters for hemodialysis vascular access: thrombolytic and mechanical correction of malfunction. Am J Kidney Dis 1996; 28: 379-86.
9. Moss AH, Vasilakis C, Holley JL, Foulks CJ, Pillai K, McDowell DE. Use of a silicone, dual-lumen catheter with a Dacron cuff as a long-term vascular access for hemodialysis patients. Am J Kidney Dis 1990; 16: 211-5.
10. Shusterman NH, Kloss K, Mullen JL. Successful use of double-lumen, silicone rubber catheters for permanent hemodialysis access. Kidney Int 1989; 35: 887-90.
11. Canaud B, Beraud JJ, Joyeux H, Mion C. Internal jugular vein cannulation with two silicone rubber catheters: a new and safe temporary vascular access for hemodialysis. Thirty months' experience. Artif Organs 1986; 10: 397-403.
12. Mokrzycki MH, Jean-Jerome K, Rush H, Zdunek MP, Rosenberg SO. A randomized trial of minidose warfarin for the prevention of late malfunction in tunneled, cuffed hemodialysis catheters. Kidney Int 2001; 59: 1935-42.
13. Webb A, Abdalla M, Russell GI. A protocol of urokinase infusion and warfarin management of the thrombosed haemodialysis catheter. Nephrol Dial Transplant 2001; 16: 2075-8.
14. Twardoski ZJ. The clotted central vein catheter for haemodialysis. Nephrol Dial Transplant 1998; 13: 2203-6.
15. Zellweger M, Bouchard J, Raymond-Carrier S, Laforest-Renald A, Quérin S, Madore F. Systemic anticoagulation and prevention of hemodialysis catheter malfunction. ASAIO J 2005; 51: 360-5.
16. Trerotola SO, Johnson MS, Harris VJ, et al. Outcome of tunnelled hemodialysis catheters placed via the right internal jugular vein by interventional radiologists. Radiology 1997; 203: 489-95.